Targeting a specific subset of neutrophils to mitigate cardiac reperfusion injury
Preprint
- 12 December 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Ischemia reperfusion (IR)-induced oxidative stress and inflammation contribute to morbidity and mortality of acute coronary syndrome. Ischemia results in profound hypoxia and tissue dysfunction and subsequent reperfusion further aggravates ischemic cardiac tissue damage. In cardiac IR injury, neutrophils are involved both in causing cardiomyocyte death and in preserving heart tissue homeostasis. We tested the hypothesis that neutrophil subpopulations show distinct functions in the pathogenesis of cardiac IR injury and that their functional heterogeneity can be exploited in subset-specific pharmacological intervention to prevent IR-induced myocardial tissue damage and functional deterioration. Cardiac IR-injury in a mouse model was characterized by the presence of two distinct heart-inflammatory subsets of neutrophils, one that specifically endocytosed albumin nanoparticles (ANP high ) and one that endocytose few or no ANP (ANP low ). The two subsets had very distinct inflammatory phenotypes. ANP high neutrophils expressed significantly greater amounts of inflammatory mediators, such as Il-1b and Ccl3, than ANP low neutrophils. Targeting the Spleen tyrosine kinase (Syk) specifically in ANP high neutrophils post IR reduced cardiac neutrophilic and mononuclear inflammation and drastically decreased infarct size, and prevented the deterioration of cardiac function. Targeting the Syk pathway specifically in a defined subset of neutrophils is a feasible therapy for cardiac IR injury.Keywords
All Related Versions
This publication has 81 references indexed in Scilit:
- Emerging albumin hydrogels as personalized biomaterialsActa Biomaterialia, 2022
- Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuriesBioactive Materials, 2021
- Resilience to Injury: A New Approach to Neuroprotection?Neurotherapeutics, 2020
- Neutrophil proteome shifts over the myocardial infarction time continuumBasic Research in Cardiology, 2019
- Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotectionBasic Research in Cardiology, 2018
- Harnessing albumin as a carrier for cancer therapiesAdvanced Drug Delivery Reviews, 2018
- Targeted non-covalent self-assembled nanoparticles based on human serum albuminBiomaterials, 2012
- Preconditioning and postconditioning: Underlying mechanisms and clinical applicationAtherosclerosis, 2009
- Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injuryCardiovascular Research, 2004
- Myocardial ischemia and reperfusion: The role of oxygen radicals in tissue injuryCardiovascular Drugs and Therapy, 1989